Diabetes Relief's Programs Can Reduce Costs to Insurance Payers
April 09, 2019 09:30 ET
|
AngioSoma, Inc.
HOUSTON, TEXAS, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma, Inc. (OTC: SOAN) is concerned that economic costs of diabetes in the USA were $327 BILLION in 2017, as reported by...
AngioSoma Announces New Facility in San Antonio for Diabetes Relief
April 01, 2019 09:30 ET
|
AngioSoma, Inc.
HOUSTON, TX, April 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma, Inc. (OTC: SOAN) announces that Diabetes Relief LLC has licensed a new facility in San Antonio, Texas for its patented...
AngioSoma Announces Acquisition of Diabetes Relief
December 14, 2018 10:57 ET
|
AngioSoma, Inc.
Houston, TX, Dec. 14, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announced today the Company has entered into a partially binding letter of intent to acquire 100% of...
New Formula of StemStrength by AngioSoma Inc. Now Available to The Public Online
October 15, 2018 06:00 ET
|
AngioSoma, Inc.
HOUSTON, TX, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma (OTC: SOAN), a leading biotechnology company, announces today the availability of the anticipated new and improved version...